Serabelisib
- Generic Name
- Serabelisib
- Drug Type
- Small Molecule
- Chemical Formula
- C19H17N5O3
- CAS Number
- 1268454-23-4
- Unique Ingredient Identifier
- 43J9Q56T3W
- Background
Serabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants).
Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer
- First Posted Date
- 2011-10-10
- Last Posted Date
- 2017-03-09
- Lead Sponsor
- Millennium Pharmaceuticals, Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT01449370
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath